| Study |
Reference |
|
Alwan, 2007
|
Alwan Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684-92
|
|
Ames (Controls unexposed, disease free), 2021
|
Ames Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biol Psychiatry 2021; 90:253-262
|
|
Ames (Controls unexposed, sick), 2021
|
Ames Maternal Psychiatric Conditions, Treatment With Selective Serotonin Reuptake Inhibitors, and Neurodevelopmental Disorders. Biol Psychiatry 2021; 90:253-262
|
|
Andersen (Controls unexposed, NOS), 2014
|
Andersen Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.,Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol 2014; 124:655-661 Johansen Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. Paediatr Perinat Epidemiol 2015; 29:72-81 Kjaersgaard Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PLoS One 2013; 8:e72095
|
|
Andersen (Controls unexposed, sick), 2014
|
Andersen Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage.,Exposure to selective serotonin reuptake inhibitors in early pregnancy and the risk of miscarriage. Obstet Gynecol 2014; 124:655-661 Johansen Maternal use of selective serotonin reuptake inhibitors and risk of miscarriage - assessing potential biases. Paediatr Perinat Epidemiol 2015; 29:72-81 Kjaersgaard Prenatal antidepressant exposure and risk of spontaneous abortion - a population-based study. PLoS One 2013; 8:e72095
|
|
Anderson, 2020
|
Alwan Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 2007; 356:2684-92 Anderson Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. JAMA Psychiatry 2020; 77:1246-1255 Lind Maternal medication and herbal use and risk for hypospadias: data from the National Birth Defects Prevention Study, 1997-2007. Pharmacoepidemiol Drug Saf 2013; 22:783-93 Nembhard Maternal and infant genetic variants, maternal periconceptional use of selective serotonin reuptake inhibitors, and risk of congenital heart defects in offspring: population based study. BMJ 2017; 356:j832 Werler Gastroschisis and Cumulative Stressor Exposures. Epidemiology 2018; 29:721-728
|
|
Andrade, 2009
|
Andrade Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2009; 18:246-52
|
|
Avalos (Controls exposed to TCA), 2015
|
Avalos Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr 2015; 20:39-47
|
|
Avalos (Controls unexposed, disease free), 2015
|
Avalos Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr 2015; 20:39-47
|
|
Avalos (Controls unexposed, sick), 2015
|
Avalos Antidepressant medication use, depression, and the risk of preeclampsia. CNS Spectr 2015; 20:39-47
|
|
Bakaysa, 2016
|
Bakaysa, S.L. Does SSRI antidepressant use influence APGAR scores? Obstet. Gynecol. 2016; 127:122S-.
|
|
Bakker - Paroxetine, 2010
|
Bakker MK First-trimester use of paroxetine and congenital heart defects: a population-based case-control study. Birth Defects Res A Clin Mol Teratol 2010;88:94-100
|
|
Ban (Controls exposed to TCA), 2014
|
Ban L Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014;121:1471-81 Petersen Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children. J Clin Psychiatry 2016; 77:e36-42
|
|
Ban (Controls exposed to TCA), 2012
|
Ban Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One 2012; 7:e43462
|
|
Ban (Controls unexposed, disease free), 2014
|
Ban L Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014;121:1471-81 Petersen Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children. J Clin Psychiatry 2016; 77:e36-42 Petersen, I. Selective serotonin reuptake inhibitors and congenital heart anomalies: Comparative cohort studies Arch. Women's Ment. Health 2015; 18:367-.
|
|
Ban (Controls unexposed, disease free), 2012
|
Ban Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One 2012; 7:e43462
|
|
Ban (Controls unexposed, sick), 2014
|
Ban L Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study. BJOG 2014;121:1471-81 Petersen Selective serotonin reuptake inhibitors and congenital heart anomalies: comparative cohort studies of women treated before and during pregnancy and their children. J Clin Psychiatry 2016; 77:e36-42 Petersen, I. Selective serotonin reuptake inhibitors and congenital heart anomalies: Comparative cohort studies Arch. Women's Ment. Health 2015; 18:367-.
|
|
Ban (Controls unexposed, sick), 2012
|
Ban Live and non-live pregnancy outcomes among women with depression and anxiety: a population-based study. PLoS One 2012; 7:e43462
|
|
Batton, 2013
|
Batton In utero antidepressant exposure and neurodevelopment in preterm infants. Am J Perinatol 2013; 30:297-301
|
|
Benevent, 2023
|
Araujo Risque d'hypertension gestationnelle chez les femmes traitées par antidépresseurs IRSNA pendant leur grossesse. Étude dans EFEMERIS. Scientific Report 2022:1-37. Benevent Risk of Hypertensive Disorders of Pregnancy in Women Treated With Serotonin-Norepinephrine Reuptake Inhibitors: A Comparative Study Using the EFEMERIS Database. J Clin Psychiatry 2023; 84:
|
|
Bérard - Non Sertraline SSRI, 2015
|
Bérard Sertraline use during pregnancy and the risk of major malformations. Am J Obstet Gynecol 2015; 212:795.e1-795.e12 Berard, A. First trimester exposure to sertraline and the risk of major congenital malformations in a cohort of depressed women Pharmacoepidemiol. Drug Saf. 2013; 22:143-. Ramos Duration of antidepressant use during pregnancy and risk of major congenital malformations. Br J Psychiatry 2008; 192:344-50
|
|
Bérard a, 2017
|
Bérard SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn. Br J Clin Pharmacol 2017; 83:1126-1133
|
|
Bérard b (Controls exposed to TCA), 2017
|
Bérard Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open 2017; 7:e013372
|
|
Bérard b (Controls unexposed, sick), 2017
|
Bérard Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort. BMJ Open 2017; 7:e013372 Bérard, A. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: A re-analysis of the Quebec pregnancy cohort Eur. Psychiatry 2017; 41:S155-.
|
|
Bernard, 2019
|
Bernard Use of antidepressants and anxiolytics in early pregnancy and the risk of preeclampsia and gestational hypertension: a prospective study. BMC Pregnancy Childbirth 2019; 19:146
|
|
Bhatt-Mehta, 2019
|
Bhatt-Mehta Impact of In-utero Exposure to Selective Serotonin Reuptake Inhibitors and Opioids on Neonatal Opioid Withdrawal Syndrome. J Addict Med 2019; 13:227-234
|
|
Bliddal (Controls unexposed, NOS), 2023
|
Bliddal, M. Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study Child Adolesc. Psychiatry Ment. Health 2023; 17:-. Talati, A. Intrauterine exposure to SSRI antidepressants and risk of emotional disorder till age 22: A Danish national register study Pharmacoepidemiol. Drug Saf. 2022; 31:474-.
|
|
Bliddal (Controls unexposed, sick), 2023
|
Bliddal, M. Prenatal antidepressant exposure and emotional disorders until age 22: a danish register study Child Adolesc. Psychiatry Ment. Health 2023; 17:-. Talati, A. Intrauterine exposure to SSRI antidepressants and risk of emotional disorder till age 22: A Danish national register study Pharmacoepidemiol. Drug Saf. 2022; 31:474-.
|
|
Boukhris (Controls exposed to TCA), 2016
|
Bérard Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort. Am J Obstet Gynecol 2016; 215:803-805 Boukhris T Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. JAMA Pediatr 2016;170:117-24
|
|
Boukhris (Controls exposed to TCA), 2017
|
Boukhris Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children. Paediatr Perinat Epidemiol 2017; 31:363-373
|
|
Boukhris (Controls unexposed, NOS), 2016
|
Bérard Selective serotonin reuptake inhibitors and autism: additional data on the Quebec Pregnancy/Birth Cohort. Am J Obstet Gynecol 2016; 215:803-805 Boukhris T Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children. JAMA Pediatr 2016;170:117-24
|
|
Boukhris (Controls unexposed, NOS), 2017
|
Boukhris Antidepressant Use in Pregnancy and the Risk of Attention Deficit with or without Hyperactivity Disorder in Children. Paediatr Perinat Epidemiol 2017; 31:363-373
|
|
Boyle, 2017
|
Boyle The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: a European registry-based study. Cardiol Young 2017; 27:677-685
|
|
Bracero, 2016
|
Bracero Relationship Between Methadone, Selective Serotonin Reuptake Inhibitors, and Neonatal Abstinence Syndrome. J Reprod Med 2016; 61:463-468
|
|
Brennan, 2023
|
Brennan Prenatal Antidepressant Exposures and Autism Spectrum Disorder or Traits: A Retrospective, Multi-Cohort Study. Res Child Adolesc Psychopathol 2023; 51:513-527
|
|
Brown, 2017
|
Brown HK Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children. JAMA 2017;317:1544-1552
|
|
Brown (Controls unexposed, disease free), 2016
|
Brown Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. JAMA Psychiatry 2016; 73:1163-1170
|
|
Brown (Controls unexposed, sick), 2016
|
Brown Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring. JAMA Psychiatry 2016; 73:1163-1170
|
|
Calderon-Margalit, 2009
|
Calderon-Margalit Risk of preterm delivery and other adverse perinatal outcomes in relation to maternal use of psychotropic medications during pregnancy. Am. J. Obstet. Gynecol. 2009; 201:579.e1-8
|
|
Cantarutti (Controls unexposed, NOS), 2016
|
Cantarutti Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation. PLoS One 2016; 11:e0168115
|
|
Cantarutti (Controls unexposed, sick), 2016
|
Cantarutti Is the Risk of Preterm Birth and Low Birth Weight Affected by the Use of Antidepressant Agents during Pregnancy? A Population-Based Investigation. PLoS One 2016; 11:e0168115
|
|
Casper, 2003
|
Casper Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J. Pediatr. 2003; 142:402-8
|
|
Chambers, 2006
|
Chambers CD Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 2006;354:579-87
|
|
Chambers - Fluoxetine, 1996
|
Chambers Birth outcomes in pregnant women taking fluoxetine. N. Engl. J. Med. 1996; 335:1010-5
|
|
Chan (Controls exposed to TCA), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Chan (Controls unexposed, general pop), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Chan (Controls unexposed, sick), 2024
|
Chan Prenatal antidepressant use and risk of congenital malformations: A population-based cohort study. Psychiatry Res 2024; 339:116038
|
|
Chen, 2021
|
Chen Association between the use of antidepressants and the risk of preterm birth among pregnant women with depression: a retrospective cohort study in Taiwan. J Investig Med 2021; 69:999-1007
|
|
Clements, 2015
|
Clements CC Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system. Mol Psychiatry 2015;20:727-34
|
|
Cohen, 2022
|
Cohen Neurobehavioral follow-up of children exposed to selective serotonin reuptake inhibitors in utero. Ann Clin Psychiatry 2022; 34:197-206
|
|
Colvin, 2011
|
Colvin L Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res A Clin Mol Teratol 2011;91:142-52
|
|
Colvin, 2012
|
Colvin Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia. CNS Drugs 2012; 26:e1-14
|
|
Cornet - SSRIs, 2024
|
Cornet Maternal treatment with selective serotonin reuptake inhibitors during pregnancy and delayed neonatal adaptation: a population-based cohort study. Arch Dis Child Fetal Neonatal Ed 2024; 109:294-300
|
|
Corti, 2019
|
Corti, S. Neonatal outcomes in maternal depression in relation to intrauterine drug exposure Frontiers in Pediatrics 2019; 7:590-.
|
|
Costei - Paroxetine (Controls unexposed, NOS), 2002
|
Costei AM Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32
|
|
Costei - Paroxetine (Controls unexposed, sick), 2002
|
Costei AM Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med 2002;156:1129-32
|
|
Croen, 2011
|
Croen LA Antidepressant use during pregnancy and childhood autism spectrum disorders. Arch Gen Psychiatry 2011;68:1104-12
|
|
Dandjinou, 2019
|
Dandjinou Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study. BMJ Open 2019; 9:e025908 Dandjinou, M. Antidepressants use during pregnancy and the risk of gestational diabetes mellitus Pharmacoepidemiol. Drug Saf. 2018; 27:378-.
|
|
Dave, 2019
|
Dave Prevalence of Maternal-Risk Factors Related to Neonatal Abstinence Syndrome in a Commercial Claims Database: 2011-2015. Pharmacotherapy 2019; 39:1005-1011
|
|
Davidson, 2009
|
Davidson Effect of exposure to selective serotonin reuptake inhibitors in utero on fetal growth: potential role for the IGF-I and HPA axes. Pediatr Res 2009; 65:236-41
|
|
Davis, 2007
|
Davis Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy. Pharmacoepidemiol Drug Saf 2007; 16:1086-94
|
|
De Jonge - Paroxetine only, 2013
|
de Jonge Identifying associations between maternal medication use and birth defects using a case-population approach: an exploratory study on signal detection. Drug Saf 2013; 36:1069-78
|
|
De Ocampo, 2016
|
De Ocampo Risk of gestational hypertension and preeclampsia in women who discontinued or continued antidepressant medication use during pregnancy. Arch Womens Ment Health 2016; 19:1051-1061
|
|
De Vera, 2012
|
De Vera Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. Br J Clin Pharmacol 2012; 74:362-9
|
|
de Vries, 2013
|
de Vries Early neurological outcome of young infants exposed to selective serotonin reuptake inhibitors during pregnancy: results from the observational SMOK study. PLoS One 2013; 8:e64654
|
|
Diav-Citrin - Fluoxetine or Paroxetine, 2008
|
Diav-Citrin Pregnancy outcome after gestational exposure to paroxetine: A prospective controlled cohort study [abstract] Teratology 2002;65:298. Diav-Citrin Paroxetine and fluoxetine in pregnancy: a multicenter, prospective, controlled study Reproductive Toxicology 2005; 20:453–491 Diav-Citrin O Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol 2008;66:695-705 Schloemp Congenital malformations after antidepressant medication with paroxetine in early pregnancy? Hum Reprod. 2006;21(Suppl I):ii 2. ESHRE abstract O-030. Winterfeld Pregnancy outcome following maternal exposure to mirtazapine: a multicenter, prospective study. J Clin Psychopharmacol 2015; 35:250-9
|
|
Dubnov-Raz, 2008
|
Dubnov-Raz Antenatal use of selective serotonin-reuptake inhibitors and QT interval prolongation in newborns. Pediatrics 2008; 122:e710-5
|
|
Edelson, 2020
|
Edelson, P.K. 745: SSRIs are not associated with increased severity of neonatal abstinence among women on opioid agonists Am. J. Obstet. Gynecol. 2020; 222:S471-.
|
|
Einarson, 2001
|
Einarson A Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 2001;158:1728-30
|
|
Einarson, 2009
|
Einarson A Incidence of major malformations in infants following antidepressant exposure in pregnancy: results of a large prospective cohort study. Can J Psychiatry 2009;54:242-6
|
|
Einarson - Paroxetine, 2008
|
Einarson A Evaluation of the risk of congenital cardiovascular defects associated with use of paroxetine during pregnancy. Am J Psychiatry 2008;165:749-52
|
|
El Marroun (Control unexposed, disease free), 2014
|
El Marroun H Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry 2014;205:95-102
|
|
El Marroun (Control unexposed, sick), 2014
|
El Marroun H Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children. Br J Psychiatry 2014;205:95-102
|
|
El Marroun (Controls unexposed, disease free), 2012
|
El Marroun Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch. Gen. Psychiatry 2012; 69:706-14
|
|
El Marroun (Controls unexposed, sick), 2012
|
El Marroun Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. Arch. Gen. Psychiatry 2012; 69:706-14
|
|
Engelstad (Controls unexposed, disease free), 2014
|
Engelstad Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Neonatology 2014; 105:149-54
|
|
Engelstad (Controls unexposed, sick), 2014
|
Engelstad Perinatal outcomes of pregnancies complicated by maternal depression with or without selective serotonin reuptake inhibitor therapy. Neonatology 2014; 105:149-54
|
|
Eriksson, 2012
|
Eriksson MA First-degree relatives of young children with autism spectrum disorders: some gender aspects. Res Dev Disabil 2012;33:1642-8
|
|
Figueroa, 2010
|
Figueroa Use of antidepressants during pregnancy and risk of attention-deficit/hyperactivity disorder in the offspring. J Dev Behav Pediatr 2010; 31:641-8
|
|
Frayne, 2021
|
Frayne The association between mental illness, psychotropic medication use and hypertensive disorders in pregnancy: A multicentre study. Pregnancy Hypertens 2021; 24:22-26
|
|
Furu (Controls unexposed, NOS), 2015
|
Furu K Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ 2015;350:h1798 Kallen The use of central nervous system active drugs during pregnancy. Pharmaceuticals (Basel) 2013; 6:1221-86 Kornum Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2010; 2:29-36 Källen Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006; 21:221-2 Malm Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106:1289-96 Pedersen Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study. BMJ 2009; 339:b3569 Wogelius Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 2006; 17:701-4
|
|
Furu (Controls unexposed, sibling), 2015
|
Furu K Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ 2015;350:h1798
|
|
Galbally (Controls unexposed, disease free), 2020
|
Galbally The mother, the infant and the mother-infant relationship: What is the impact of antidepressant medication in pregnancy. J Affect Disord 2020; 272:363-370
|
|
Galbally (Controls unexposed, sick), 2020
|
Galbally The mother, the infant and the mother-infant relationship: What is the impact of antidepressant medication in pregnancy. J Affect Disord 2020; 272:363-370
|
|
Giardinelli (Controls unexposed, disease free), 2018
|
Giardinelli Comparison of two different treatments in depressed pregnant women: fetal growth characteristics and neonatal outcomes. J Perinat Med 2018; 47:134-137
|
|
Giardinelli (Controls unexposed, sick), 2018
|
Giardinelli Comparison of two different treatments in depressed pregnant women: fetal growth characteristics and neonatal outcomes. J Perinat Med 2018; 47:134-137
|
|
Given, 2017
|
Given Gastroschisis in Europe - A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk Factors. Paediatr Perinat Epidemiol 2017; 31:549-559
|
|
Gover, 2023
|
Gover The Effect of SSRI Exposure in Pregnancy on Early Respiratory and Metabolic Adaptation in Infants Born Preterm. Children (Basel) 2023; 10:
|
|
Granstrom, 2019
|
Granstrom Selective serotonin reuptake inhibitors during pregnancy Do not increase the risk of Hirschsprung disease. J Pediatr Surg 2019; 54:2398-2401
|
|
Grzeskowiak (Controls unexposed, disease free), 2013
|
Grzeskowiak LE Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age. Ann Epidemiol 2013;23:681-7
|
|
Grzeskowiak (Controls unexposed, sick), 2013
|
Grzeskowiak LE Prenatal exposure to selective serotonin reuptake inhibitors and childhood overweight at 7 years of age. Ann Epidemiol 2013;23:681-7
|
|
Grzeskowiak a (Controls unexposed, disease free), 2012
|
Grzeskowiak LE Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors. J Clin Psychopharmacol 2012;32:615-21
|
|
Grzeskowiak a (Controls unexposed, sick), 2012
|
Grzeskowiak LE Neonatal outcomes after late-gestation exposure to selective serotonin reuptake inhibitors. J Clin Psychopharmacol 2012;32:615-21
|
|
Grzeskowiak b (Controls unexposed, disease free), 2012
|
Grzeskowiak LE Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight. J Dev Orig Health Dis 2012;3:253-61
|
|
Grzeskowiak b (Controls unexposed, sick), 2012
|
Grzeskowiak LE Prenatal exposure to selective serotonin reuptake inhibitors and risk of childhood overweight. J Dev Orig Health Dis 2012;3:253-61
|
|
Gungor (Controls exposed to Mirtazapine), 2019
|
Gungor, B.B. Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Psychiatry and Clinical Psychopharmacology 2019; 29:822-.
|
|
Gungor (Controls unexposed, disease free), 2019
|
Gungor, B.B. Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Psychiatry and Clinical Psychopharmacology 2019; 29:822-.
|
|
Gungor (Controls unexposed, sick), 2019
|
Gungor, B.B. Comparison of the groups treated with mirtazapine and selective serotonine reuptake inhibitors with respect to birth outcomes and severity of psychiatric disorder Psychiatry and Clinical Psychopharmacology 2019; 29:822-.
|
|
Hagberg (Controls exposed to TCA), 2018
|
Hagberg Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol 2018; 10:1599-1612
|
|
Hagberg (Controls unexposed, disease free), 2018
|
Hagberg Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol 2018; 10:1599-1612
|
|
Hagberg (Controls unexposed, sick), 2018
|
Hagberg Maternal depression and antidepressant use during pregnancy and the risk of autism spectrum disorder in offspring. Clin Epidemiol 2018; 10:1599-1612
|
|
Handal a, 2016
|
Handal M Motor development in children prenatally exposed to selective serotonin reuptake inhibitors: a large population-based pregnancy cohort study. BJOG 2016;123:1908-1917
|
|
Hanley, 2016
|
Hanley Postpartum Hemorrhage and Use of Serotonin Reuptake Inhibitor Antidepressants in Pregnancy. Obstet Gynecol 2016; 127:553-561
|
|
Hannerfors (Controls unexposed, NOS), 2015
|
Hannerfors Treatment with serotonin reuptake inhibitors during pregnancy is associated with elevated corticotropin-releasing hormone levels. Psychoneuroendocrinology 2015; 58:104-13
|
|
Hannerfors (Controls unexposed, sick), 2015
|
Hannerfors Treatment with serotonin reuptake inhibitors during pregnancy is associated with elevated corticotropin-releasing hormone levels. Psychoneuroendocrinology 2015; 58:104-13
|
|
Harrington, 2014
|
Harrington RA Prenatal SSRI use and offspring with autism spectrum disorder or developmental delay. Pediatrics 2014;133:e1241-8
|
|
Hartwig, 2022
|
Hartwig In utero antidepressant exposure not associated with ADHD in the offspring: A case control sibling design. Front Pharmacol 2022; 13:1000018
|
|
Heikkinen - Citalopram only, 2002
|
Heikkinen Citalopram in pregnancy and lactation. Clin Pharmacol Ther 2002; 72:184-91
|
|
Heikkinen - Fluoxetine only, 2003
|
Heikkinen Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation. Clin Pharmacol Ther 2003; 73:330-7
|
|
Heinonen - Sertraline, 2021
|
Heinonen Sertraline concentrations in pregnant women are steady and the drug transfer to their infants is low. Eur J Clin Pharmacol 2021; 77:1323-1331
|
|
Heuvelman, 2023
|
Heuvelman Antidepressants in pregnancy: applying causal epidemiological methods to understand service-use outcomes in women and long-term neurodevelopmental outcomes in exposed children. Health Technol Assess 2023; 27:1-83
|
|
Hogue, 2017
|
Hogue Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants.,Effects of in-utero exposure to selective serotonin reuptake inhibitors and venlafaxine on term and preterm infants. J Neonatal Perinatal Med 2017; 10:371-380
|
|
Hutchison a, 2019
|
Hutchison Impact of Prenatal Selective Serotonin Reuptake Inhibitor Antidepressant Exposure and Maternal Mood on Physical Activity, Dietary Intake, and Markers of Adiposity at Age 6 Years. J Dev Behav Pediatr 2019; 40:266-274
|
|
Hutchison b, 2019
|
Hutchison A 6-year longitudinal study: Are maternal depressive symptoms and Selective Serotonin Reuptake Inhibitor (SSRI) antidepressant treatment during pregnancy associated with everyday measures of executive function in young children? Early Hum Dev 2019; 128:21-26
|
|
Huybrechts (Controls unexposed, NOS), 2014
|
Huybrechts KF Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014;370:2397-407
|
|
Huybrechts (Controls unexposed, NOS), 2015
|
Huybrechts Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 2015; 313:2142-51
|
|
Huybrechts (Controls unexposed, sick), 2015
|
Huybrechts Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA 2015; 313:2142-51
|
|
Huybrechts (Controls unexposed, sick), 2014
|
Huybrechts KF Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med 2014;370:2397-407
|
|
Isohata, 2025
|
Isohata The impact of the number of non-opioid psychotropic medications and their co-exposures during pregnancy on short-term outcomes in full-term neonates. Sci Rep 2025; 15:30853
|
|
Jackson, 2024
|
Jackson, F.I. Association between psychopharmacotherapy and postpartum hemorrhage AJOG Glob. Rep. 2024; 4:360-.
|
|
Jaeger, 2019
|
Jaeger, K.M. Effect of Selective Serotonin Reuptake Inhibitor Use During Pregnancy On Maternal And Neonatal Outcomes Among Women With Depression In The United States Military Healthcare System: A Retrospective Cohort Study J. Adolesc. Health 2019; 64:S66-.
|
|
Jensen b, 2013
|
Jensen Maternal depression, antidepressant use in pregnancy and Apgar scores in infants. Br J Psychiatry 2013; 202:347-51
|
|
Jimenez-Solem (Controls unexposed, NOS), 2012
|
Jimenez-Solem Exposure to antidepressants during pregnancy--prevalences and outcomes. Dan Med J 2014; 61:B4916 Jimenez-Solem E Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012;2: Kornum Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2010; 2:29-36
|
|
Jimenez-Solem (Controls unexposed, sick), 2012
|
Jimenez-Solem Exposure to antidepressants during pregnancy--prevalences and outcomes. Dan Med J 2014; 61:B4916 Jimenez-Solem E Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open 2012;2: Kornum Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol 2010; 2:29-36
|
|
Jordan, 2016
|
Jordan S Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in Pregnancy and Congenital Anomalies: Analysis of Linked Databases in Wales, Norway and Funen, Denmark. PLoS One 2016;11:e0165122 Knudsen Increased risk of severe congenital heart defects in offspring exposed to selective serotonin-reuptake inhibitors in early pregnancy--an epidemiological study using validated EUROCAT data. BMC Pregnancy Childbirth 2014; 14:333
|
|
Källén, 2007
|
Källen Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations. Birth Defects Res A Clin Mol Teratol 2007;79:301-8 Källen Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006; 21:221-2 Lennestal Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 2007; 27:607-13
|
|
Källén (Controls exposed to TCA), 2004
|
Källen Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004;158:312-6
|
|
Källén (Controls unexposed, NOS), 2004
|
Källen Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med 2004;158:312-6
|
|
Kawai, 2023
|
Kawai Association Between Maternal Factors in Early Pregnancy and Congenital Heart Defects in Offspring: The Japan Environment and Children's Study. J Am Heart Assoc 2023; 12:e029268
|
|
Kerr, 2018
|
Kerr Risk factors for congenital microcephaly in the pre-Zika era. Birth Defects Res 2019; 111:96-118
|
|
Kieler, 2012
|
Kieler H Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries. BMJ 2012;344:d8012 Källen Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn. Pharmacoepidemiol Drug Saf 2008; 17:801-6 Norby Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy. Pediatrics 2016; 138:
|
|
Kieler, 2015
|
Kieler Use of antidepressants and association with elective termination of pregnancy: population based case-control study. BJOG 2015; 122:1618-24
|
|
Kildegaard, 2025
|
Kildegaard Prenatal exposure to selective serotonin reuptake inhibitors and risk of disorders of gut-brain interaction in children. Mol Psychiatry 2025; 30:2448-2456
|
|
Kitchin, 2022
|
Kitchin The role of prenatal exposure to antidepressants, anxiolytic, and hypnotics and its underlying illness on the risk of miscarriage using BIFAP database. Pharmacoepidemiol Drug Saf 2022; :
|
|
Kivistö, 2016
|
Kivisto Maternal Use of Selective Serotonin Reuptake Inhibitors and Lengthening of the Umbilical Cord: Indirect Evidence of Increased Foetal Activity-A Retrospective Cohort Study. PLoS One 2016; 11:e0154628
|
|
Klieger-Grossmann - Escitalopram, 2012
|
Klieger-Grossmann Pregnancy outcomes following use of escitalopram: a prospective comparative cohort study. J Clin Pharmacol 2012; 52:766-70
|
|
Knickmeyer, 2014
|
Knickmeyer Rate of Chiari I malformation in children of mothers with depression with and without prenatal SSRI exposure. Neuropsychopharmacology 2014; 39:2611-21
|
|
Kolding (Controls unexposed, disease free), 2021
|
Kolding Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG 2021; 128:1949-1957
|
|
Kolding (Controls unexposed, sick), 2021
|
Kolding Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study. BJOG 2021; 128:1949-1957
|
|
Kragholm, 2018
|
Kragholm Exposure to selective serotonin reuptake inhibitors in utero and early elementary school outcomes. Acta Psychiatr Scand 2018; 137:481-490
|
|
Kulin, 1998
|
Kulin NA Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study. JAMA 1998;279:609-10
|
|
Laspro - Sertraline, 2024
|
Laspro Association of Commonly Prescribed Antepartum Medications and Incidence of Orofacial Clefting. Cleft Palate Craniofac J 2024; :10556656241237679
|
|
Latendresse, 2011
|
Latendresse Maternal corticotropin-releasing hormone and the use of selective serotonin reuptake inhibitors independently predict the occurrence of preterm birth. J Midwifery Womens Health ; 56:118-26
|
|
Laugesen, 2013
|
Laugesen In utero exposure to antidepressant drugs and risk of attention deficit hyperactivity disorder: a nationwide Danish cohort study. BMJ Open 2013; 3:e003507
|
|
Lee (Controls exposed to TCAs), 2025
|
Lee Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003-2018. Eur Neuropsychopharmacol 2025; 96:36-45
|
|
Lee (Controls unexposed, general pop), 2024
|
Lee Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspring. Eur Child Adolesc Psychiatry 2024; :
|
|
Lee (Controls unexposed, general pop), 2025
|
Lee Antidepressant use during pregnancy and risk of obstetrics and neonatal outcomes: A propensity score-weighted population-based cohort study in 2003-2018. Eur Neuropsychopharmacol 2025; 96:36-45
|
|
Lee (Controls unexposed, sibling), 2024
|
Lee Association between maternal antidepressant use during pregnancy and the risk of autism spectrum disorder and attention deficit hyperactivity disorder in offspring. Eur Child Adolesc Psychiatry 2024; :
|
|
Lennestal, 2007
|
Lennestal Delivery outcome in relation to maternal use of some recently introduced antidepressants. J Clin Psychopharmacol 2007; 27:607-13
|
|
Levinson-Castiel, 2006
|
Levinson-Castiel Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med 2006; 160:173-6
|
|
Levy, 2020
|
Levy Maternal use of SSRIs during pregnancy - neonatal outcomes in correlation with placental histopathology. American Journal of Obstetrics and Gynecology 2020, 1:S224-S225. Levy Maternal use of selective serotonin reuptake inhibitors (SSRI) during pregnancy-neonatal outcomes in correlation with placental histopathology. J Perinatol 2020; 40:1017-1024
|
|
Liu, 2017
|
Liu Antidepressant use during pregnancy and psychiatric disorders in offspring: Danish nationwide register based cohort study. BMJ 2017; 358:j3668
|
|
Liu, 2015
|
Liu Antidepressant use during pregnancy and asthma in the offspring. Pediatrics 2015; 135:e911-7
|
|
Louik, 2007
|
Louik First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N. Engl. J. Med. 2007; 356:2675-83
|
|
Louik, 2014
|
Louik First-trimester exposure to bupropion and risk of cardiac malformations. Pharmacoepidemiol Drug Saf 2014; 23:1066-75
|
|
Lund (Controls unexposed, disease free), 2009
|
Lund N Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009;163:949-54
|
|
Lund (Controls unexposed, sick), 2009
|
Lund N Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes. Arch Pediatr Adolesc Med 2009;163:949-54
|
|
Lupattelli (Controls exposed to TCA), 2017
|
Lupattelli Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study. Pharmacoepidemiol Drug Saf 2017; 26:1266-1276
|
|
Lupattelli (Controls unexposed, disease free), 2014
|
Lupattelli Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2014; 34:143-8
|
|
Lupattelli (Controls unexposed, sick), 2017
|
Lupattelli Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study. Pharmacoepidemiol Drug Saf 2017; 26:1266-1276
|
|
Lupattelli (Controls unexposed, sick), 2014
|
Lupattelli Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2014; 34:143-8
|
|
Lyn, 2023
|
Lyn, C.E. Evaluation of antidepressant use in pregnancy and Apgar score at birth: a retrospective single centre australian study. J. Paediatr. Child Health 2023; 59:67-.
|
|
Malm, 2011
|
Malm H Selective serotonin reuptake inhibitors and risk for major congenital anomalies. Obstet Gynecol 2011;118:111-20
|
|
Malm (Controls unexposed, disease free), 2015
|
Malm Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106:1289-96 Malm H Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data. Am J Psychiatry 2015;172:1224-32
|
|
Malm (Controls unexposed, disease free), 2016
|
Malm Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study. J Am Acad Child Adolesc Psychiatry 2016; 55:359-66
|
|
Malm (Controls unexposed, sick), 2015
|
Malm Risks associated with selective serotonin reuptake inhibitors in pregnancy. Obstet Gynecol 2005; 106:1289-96 Malm H Pregnancy Complications Following Prenatal Exposure to SSRIs or Maternal Psychiatric Disorders: Results From Population-Based National Register Data. Am J Psychiatry 2015;172:1224-32
|
|
Malm (Controls unexposed, sick), 2016
|
Malm Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study. J Am Acad Child Adolesc Psychiatry 2016; 55:359-66
|
|
Man, 2015
|
Man K Prenatal antidepressant exposure and the risk of autism spectrum disorder and attention-deficit hyperactivity disorder, Pharmacoepidemiol. Drug Saf. 24 (2015) 234 (Issue Supplement S1).
|
|
Man (Controls exposed to antipsychotics), 2017
|
Man Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study BMJ 2017;357:j2350 Man Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study. BMJ 2017; 357:j2350
|
|
Man (Controls unexposed, NOS), 2017
|
Man Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study BMJ 2017;357:j2350
|
|
Manakova, 2011
|
Manakova Antidepressant drug exposure during pregnancy. CZTIS small prospective study.,Antidepressant drug exposure during pregnancy. CZTIS small prospective study. Neuro Endocrinol Lett 2011; 32 Suppl 1:53-6
|
|
Margulis, 2013
|
Margulis Use of selective serotonin reuptake inhibitors in pregnancy and cardiac malformations: a propensity-score matched cohort in CPRD. Pharmacoepidemiol Drug Saf 2013; 22:942-51
|
|
Marks - Sertraline (Controls exposed to Bupropion), 2021
|
Marks Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy 2021; 41:907-914
|
|
Marks - Sertraline (Controls unexposed, sick), 2021
|
Marks Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study. Pharmacotherapy 2021; 41:907-914
|
|
Martin - Sertraline, 2024
|
Martin Antidepressant use during pregnancy and birth outcomes: analysis of electronic health data from the UK, Norway, and Sweden. medRxiv 2024; :
|
|
Maschi - Fluoxetine, 2008
|
Maschi S Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008;115:283-9
|
|
Maschi - Paroxetine, 2008
|
Maschi S Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study. BJOG 2008;115:283-9
|
|
Merlob, 2009
|
Merlob P Are selective serotonin reuptake inhibitors cardiac teratogens? Echocardiographic screening of newborns with persistent heart murmur. Birth Defects Res A Clin Mol Teratol 2009;85:837-41
|
|
Misri, 2006
|
Misri Internalizing behaviors in 4-year-old children exposed in utero to psychotropic medications. Am J Psychiatry 2006; 163:1026-32. Oberlander Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 2010; 164:444-51
|
|
Morimoto, 2021
|
Morimoto Head circumference in infants with nonopiate-induced neonatal abstinence syndrome. CNS Spectr 2021; 26:509-512
|
|
Mulder, 2011
|
Mulder Selective serotonin reuptake inhibitors affect neurobehavioral development in the human fetus. Neuropsychopharmacology 2011; 36:1961-71
|
|
Nakhai-Pour, 2010
|
Nakhai-Pour Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 2010; 182:1031-7 Nakhai-Pour, H.R. Antidepressant medication use during pregnancy and the risk of miscarriage Pharmacoepidemiol. Drug Saf. 2009; 18:S76-. Nakhai-Pour, H.R. Antidepressant medication use during pregnancy and the risk of miscarriage Birth Defects Res. Part A Clin. Mol. Teratol. 2009; 85:437-.
|
|
Neo, 2020
|
Neo Prenatal selective serotonin reuptake inhibitors and therapeutic hypothermia for suspected hypoxic ischemic encephalopathy. J Perinatol 2020; 40:640-645
|
|
Nielsen, 2017
|
Nielsen Maternal use of selective serotonin reuptake inhibitors during pregnancy is associated with Hirschsprung's disease in newborns - a nationwide cohort study. Orphanet J Rare Dis 2017; 12:116
|
|
Nijenhuis (Controls exposed to TCA), 2012
|
Nijenhuis Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. Br J Clin Pharmacol 2012; 73:126-34
|
|
Nijenhuis (Controls unexposed, NOS), 2012
|
Nijenhuis Disturbed development of the enteric nervous system after in utero exposure of selective serotonin re-uptake inhibitors and tricyclic antidepressants. Part 2: Testing the hypotheses. Br J Clin Pharmacol 2012; 73:126-34
|
|
Nishigori, 2017
|
Nishigori Selective serotonin reuptake inhibitors and risk of major congenital anomalies for pregnancies in Japan: A nationwide birth cohort study of the Japan Environment and Children's Study. 2017; 57:72-78
|
|
Norby, 2016
|
Norby Neonatal Morbidity After Maternal Use of Antidepressant Drugs During Pregnancy. Pediatrics 2016; 138: Viktorin Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age. Int J Epidemiol 2016; 45:170-7
|
|
Nordeng (Controls unexposed, NOS), 2012
|
Nordeng H Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2012;32:186-94
|
|
Nordeng (Controls unexposed, sick), 2012
|
Nordeng H Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian Mother and Child Cohort Study. J Clin Psychopharmacol 2012;32:186-94
|
|
Nulman (Controls unexposed, disease free), 2012
|
Nulman I Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 2012;169:1165-74
|
|
Nulman (Controls unexposed, sick), 2012
|
Nulman I Neurodevelopment of children following prenatal exposure to venlafaxine, selective serotonin reuptake inhibitors, or untreated maternal depression. Am J Psychiatry 2012;169:1165-74
|
|
Nulman - Fluoxetine (Controls exposed to TCA), 1997
|
Nulman I Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62
|
|
Nulman - Fluoxetine (Controls exposed to TCA), 2002
|
Nulman Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889-95
|
|
Nulman - Fluoxetine (Controls unexposed, disease free), 2002
|
Nulman Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study. Am J Psychiatry 2002; 159:1889-95
|
|
Nulman - Fluoxetine (Controls unexposed, NOS), 1997
|
Nulman I Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62
|
|
Oberlander, 2004
|
Oberlander Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure. Pediatrics 2005; 115:411-25 Oberlander Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-7 Reebye Affect expression in prenatally psychotropic exposed and nonexposed mother–infant dyads. Infant Ment Health J. 2002;23(4):403–416 Weikum The impact of prenatal serotonin reuptake inhibitor (SRI) antidepressant exposure and maternal mood on mother-infant interactions at 3 months of age. Infant Behav Dev 2013; 36:485-93
|
|
Oberlander, 2007
|
Oberlander Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-7 Oberlander Prenatal effects of selective serotonin reuptake inhibitor antidepressants, serotonin transporter promoter genotype (SLC6A4), and maternal mood on child behavior at 3 years of age. Arch Pediatr Adolesc Med 2010; 164:444-51 Oberlander Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy. Arch Pediatr Adolesc Med 2007; 161:22-9
|
|
Oberlander a, 2008
|
Oberlander TF Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 2008;83:68-76
|
|
Ogawa, 2018
|
Ogawa Maternal exposure to benzodiazepine and risk of preterm birth and low birth weight: A case-control study using a claims database in Japan. Asia Pac Psychiatry 2018; 10:e12309
|
|
Olstad - (Es)citalopram (Controls unexposed, disease free), 2023
|
Olstad Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopment. Transl Psychiatry 2023; 13:149
|
|
Olstad - (Es)citalopram (Controls unexposed, sick), 2023
|
Olstad Effects of prenatal exposure to (es)citalopram and maternal depression during pregnancy on DNA methylation and child neurodevelopment. Transl Psychiatry 2023; 13:149
|
|
Ozturk - Escitalopram, 2016
|
Ozturk Safety of psychotropic medications in pregnancy: An observational cohort study Klinik Psikofarmakoloji Bulteni 2016; 26:229-237.
|
|
Palmsten, 2020
|
Palmsten Patterns of prenatal antidepressant exposure and risk of preeclampsia and postpartum haemorrhage. Paediatr Perinat Epidemiol 2020; 34:597-606
|
|
Palmsten (control exposed to TCA), 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
|
Palmsten (Controls exposed to TCA), 2012
|
Palmsten Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Am. J. Epidemiol. 2012; 175:988-97
|
|
Palmsten (Controls unexposed, sick), 2013
|
Palmsten Antidepressant use and risk for preeclampsia. Epidemiology 2013; 24:682-91
|
|
Palmsten (Controls unexposed, sick), 2012
|
Palmsten Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants? Am. J. Epidemiol. 2012; 175:988-97
|
|
Palmsten b, 2013
|
Palmsten Use of antidepressants near delivery and risk of postpartum hemorrhage: cohort study of low income women in the United States. BMJ 2013; 347:f4877
|
|
Pastuszak - Fluoxetine (Controls exposed to TCA), 1993
|
Pastuszak A Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) JAMA 1993;269:2246-8
|
|
Pastuszak - Fluoxetine (Controls unexposed, NOS), 1993
|
Pastuszak A Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac) JAMA 1993;269:2246-8
|
|
Pearson (Controls exposed to TCA), 2007
|
Pearson Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry 2007; 68:1284-9
|
|
Pearson (Controls unexposed, NOS), 2007
|
Pearson Birth outcomes following prenatal exposure to antidepressants. J Clin Psychiatry 2007; 68:1284-9
|
|
Pedersen, 2010
|
Pedersen Fetal exposure to antidepressants and normal milestone development at 6 and 19 months of age. Pediatrics 2010; 125:e600-8
|
|
Rai (Controls exposed to TCA), 2017
|
Rai Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017; 358:j2811 Rai Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013; 346:f2059
|
|
Rai (Controls unexposed, disease free), 2017
|
Rai Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017; 358:j2811 Rai Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013; 346:f2059
|
|
Rai (Controls unexposed, sick), 2017
|
Rai Antidepressants during pregnancy and autism in offspring: population based cohort study. BMJ 2017; 358:j2811 Rai Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study. BMJ 2013; 346:f2059
|
|
Rampono, 2009
|
Rampono Placental transfer of SSRI and SNRI antidepressants and effects on the neonate. Pharmacopsychiatry 2009; 42:95-100
|
|
Raviv, 2025
|
Raviv The association between gestational selective serotonin reuptake inhibitor (SSRI) treatment and newborn thyroid screen: a large-scale cohort study. BMC Pediatr 2025; 25:74
|
|
Reebye, 2002
|
Oberlander Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure. J Clin Psychiatry 2004; 65:230-7 Reebye Affect expression in prenatally psychotropic exposed and nonexposed mother–infant dyads. Infant Ment Health J. 2002;23(4):403–416 Reebye, P.N. Affect expression and self-regulation capacities of infants exposed in utero to psychotropics Front. Psychiatry 2012; 3:366-.
|
|
Reis (Controls exposed to TCA), 2010
|
Källen Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006; 21:221-2 Källen Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy. J Clin Psychopharmacol 2012; 32:608-14 Reis Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40:1723-33
|
|
Reis (Controls unexposed, NOS), 2010
|
Källen Antidepressant drugs during pregnancy and infant congenital heart defect. Reprod Toxicol 2006; 21:221-2 Källen Neonatal complications after maternal concomitant use of SSRI and other central nervous system active drugs during the second or third trimester of pregnancy. J Clin Psychopharmacol 2012; 32:608-14 Reis Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40:1723-33
|
|
Richardson, 2019
|
Martin, F. Fetal effects of serotonin-noradrenaline reuptake inhibitor use during pregnancy Drug Saf. 2018; 41:1124-. Richardson Pregnancy outcomes following maternal venlafaxine use: A prospective observational comparative cohort study. Reprod Toxicol 2019; 84:108-113
|
|
Robinson-Wolrath, 2016
|
Robinson-Wolrath, S. SSRI and SNRI use during pregnancy is associated with both obstetric and neonatal complications BJOG Int. J. Obstet. Gynaecol. 2016; 123:168-.
|
|
Roca, 2011
|
Roca A Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. J Affect Disord 2011;135:208-15
|
|
Rommel, 2022
|
Jensen The effects of maternal depression and use of antidepressants during pregnancy on risk of a child small for gestational age. Psychopharmacology (Berl.) 2013; 228:199-205 Rommel Antidepressant use during pregnancy and risk of adverse neonatal outcomes: A comprehensive investigation of previously identified associations. Acta Psychiatr Scand 2022; 145:544-556
|
|
Sahingöz (Controls unexposed, disease free), 2014
|
Sahingöz Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. J Clin Psychopharmacol 2014; 34:226-9
|
|
Sahingöz (Controls unexposed, sick), 2014
|
Sahingöz Birth weight and preterm birth in babies of pregnant women with major depression in relation to treatment with antidepressants. J Clin Psychopharmacol 2014; 34:226-9
|
|
Salisbury (Controls unexposed, disease free), 2016
|
Salisbury The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Am J Psychiatry 2016; 173:147-57 Salisbury Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety 2011; 28:1008-19
|
|
Salisbury (Controls unexposed, sick), 2016
|
Salisbury The Roles of Maternal Depression, Serotonin Reuptake Inhibitor Treatment, and Concomitant Benzodiazepine Use on Infant Neurobehavioral Functioning Over the First Postnatal Month. Am J Psychiatry 2016; 173:147-57 Salisbury Newborn neurobehavioral patterns are differentially related to prenatal maternal major depressive disorder and serotonin reuptake inhibitor treatment. Depress Anxiety 2011; 28:1008-19
|
|
Salkeld, 2008
|
Salkeld The risk of postpartum hemorrhage with selective serotonin reuptake inhibitors and other antidepressants. J Clin Psychopharmacol 2008; 28:230-4
|
|
Scannell, 2020
|
Scannell, M.L. Does treating depression in pregnant women with diabetes improve diabetes-related pregnancy outcomes? Diabetes 2020; 69:1-.
|
|
Simon (Controls exposed to TCA), 2002
|
Simon Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055-61
|
|
Simon (Controls unexposed, NOS), 2002
|
Simon Outcomes of prenatal antidepressant exposure. Am J Psychiatry 2002; 159:2055-61
|
|
Sivojelezova - Citalopram, 2005
|
Sivojelezova A Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome. Am J Obstet Gynecol 2005;193:2004-9
|
|
Sjaarda, 2020
|
Sjaarda Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss. Fertil Steril 2020; 114:1278-1287
|
|
Skalkidou (Controls unexposed, disease free), 2020
|
Skalkidou SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden. BJOG 2020; 127:1366-1373
|
|
Skalkidou (Controls unexposed, sick), 2020
|
Skalkidou SSRI use during pregnancy and risk for postpartum haemorrhage: a national register-based cohort study in Sweden. BJOG 2020; 127:1366-1373
|
|
Skurtveit, 2014
|
Skurtveit Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway. BJOG 2014; 121:1621-31
|
|
Smith, 2013
|
Smith Neurobehavioral assessment of infants born at term and in utero exposure to serotonin reuptake inhibitors. Early Hum Dev 2013; 89:81-6
|
|
Solé, 2020
|
Solé Obstetric complications in bipolar disorder: Psychiatric factors and the risk of caesarean section. Eur Neuropsychopharmacol 2020; 32:47-55
|
|
Stephansson, 2013
|
Jimenez-Solem SSRI use during pregnancy and risk of stillbirth and neonatal mortality. Am J Psychiatry 2013; 170:299-304 Stephansson Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality. JAMA 2013; 309:48-54
|
|
Suarez (Controls unexposed, discontinuers), 2022
|
Suarez Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children. JAMA Intern Med 2022; 182:1149-60
|
|
Suarez (Controls unexposed, general pop), 2022
|
Suarez Association of Antidepressant Use During Pregnancy With Risk of Neurodevelopmental Disorders in Children. JAMA Intern Med 2022; 182:1149-60
|
|
Sujan (Controls unexposed, NOS), 2017
|
Reis Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med 2010; 40:1723-33 Sujan Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring. JAMA 2017; 317:1553-1562 Viktorin Autism risk following antidepressant medication during pregnancy. Psychol Med 2017; 47:2787-2796 Viktorin Selective serotonin re-uptake inhibitor use during pregnancy: association with offspring birth size and gestational age. Int J Epidemiol 2016; 45:170-7
|
|
Sujan (Controls unexposed, sibling), 2017
|
Sujan Associations of Maternal Antidepressant Use During the First Trimester of Pregnancy With Preterm Birth, Small for Gestational Age, Autism Spectrum Disorder, and Attention-Deficit/Hyperactivity Disorder in Offspring. JAMA 2017; 317:1553-1562
|
|
Suri, 2007
|
Suri Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 2007; 164:1206-13
|
|
Suri - Fluoxetine (Controls unexposed, disease free), 2004
|
Suri The impact of depression and fluoxetine treatment on obstetrical outcome. Arch Womens Ment Health 2004; 7:193-200
|
|
Suri - Fluoxetine (Controls unexposed, sick), 2004
|
Suri The impact of depression and fluoxetine treatment on obstetrical outcome. Arch Womens Ment Health 2004; 7:193-200
|
|
Sørensen (Controls exposed to TCA), 2013
|
Gidaya In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord 2014; 44:2558-67 Hviid Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 2013; 369:2406-15 Sorensen MJ Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 2013;5:449-59
|
|
Sørensen (Controls unexposed, NOS), 2013
|
Gidaya In utero exposure to selective serotonin reuptake inhibitors and risk for autism spectrum disorder. J Autism Dev Disord 2014; 44:2558-67 Gidaya, N.B. In utero exposure to selective serotonin reuptake inhibitors (SSRIS) and risk for AUTISM SPECTRUM DISORDERS (ASD) Am. J. Epidemiol. 2012; 175:S127-. Hviid Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism. N Engl J Med 2013; 369:2406-15 Hviid, A. Use of selective serotonin reuptake inhibitors during pregnancy and risk for autism Obstet. Gynecol. Surv. 2014; 69:187-. Sorensen MJ Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 2013;5:449-59
|
|
Sørensen (Controls unexposed, sibling), 2013
|
Sorensen MJ Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 2013;5:449-59
|
|
Sørensen (Controls unexposed, sick), 2013
|
Sorensen MJ Antidepressant exposure in pregnancy and risk of autism spectrum disorders. Clin Epidemiol 2013;5:449-59
|
|
Talati (Controls unexposed, general pop), 2025
|
Talati Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records-Based Cohort Study. J Am Acad Child Adolesc Psychiatry 2025; :
|
|
Talati (Controls unexposed, sick), 2025
|
Talati Prenatal Antidepressant Exposure and Risk of Depression and Anxiety Disorders: An Electronic Health Records-Based Cohort Study. J Am Acad Child Adolesc Psychiatry 2025; :
|
|
Ter Host (Controls exposed to TCA), 2013
|
ter Horst In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children. Eur J Clin Pharmacol 2013; 69:541-7
|
|
Ter Host (Controls unexposed, NOS), 2013
|
ter Horst In utero exposure to antidepressants and the use of drugs for pulmonary diseases in children. Eur J Clin Pharmacol 2013; 69:541-7
|
|
Toh a, 2009
|
Toh Selective serotonin reuptake inhibitor use and risk of gestational hypertension. Am J Psychiatry 2009; 166:320-8
|
|
Toh b, 2009
|
Toh Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction. J Clin Psychopharmacol 2009; 29:555-60
|
|
Tran (Controls exposed to TCA), 2022
|
Tran Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res 2022; 146:92-101
|
|
Tran (Controls unexposed, NOS), 2022
|
Tran Antidepressant use during pregnancy and development of preeclampsia: A focus on classes of action and specific transporters/receptors targeted by antidepressants. J Psychiatr Res 2022; 146:92-101
|
|
Ulbrich, 2021
|
Ulbrich Acute Delivery Room Resuscitation of Neonates Exposed to Selective Serotonin Reuptake Inhibitors. J Pediatr 2021; 232:103-108.e2 Ulbrich Identifying need for acute resuscitation in delivery room for SSRI exposed neonates Birth Defects Res. 2019; 111:555-.
|
|
Van der Veere, 2020
|
van der Veere Intra-uterine exposure to selective serotonin reuptake inhibitors (SSRIs), maternal psychopathology, and neurodevelopment at age 2.5years - Results from the prospective cohort SMOK study. Early Hum Dev 2020; 147:105075
|
|
Vasilakis-Scaramozza (Controls exposed to TCA), 2013
|
Vasilakis-Scaramozza Antidepressant use during early pregnancy and the risk of congenital anomalies. Pharmacotherapy 2013; 33:693-700
|
|
Vasilakis-Scaramozza (Controls unexposed, NOS), 2013
|
Vasilakis-Scaramozza Antidepressant use during early pregnancy and the risk of congenital anomalies. Pharmacotherapy 2013; 33:693-700
|
|
Vial - Paroxetine, 2006
|
Vial Paroxetine and congenital malformations: A prospective comparative study Drug Saf. 2006, 29: 911-1010.
|
|
Viktorin, 2017
|
Viktorin Association of Antidepressant Medication Use During Pregnancy With Intellectual Disability in Offspring. JAMA Psychiatry 2017; 74:1031-1038
|
|
Viktorin b, 2017
|
Viktorin Autism risk following antidepressant medication during pregnancy. Psychol Med 2017; 47:2787-2796
|
|
Wall-Wieler, 2020
|
Wall-Wieler Antidepressant Use around Conception, Prepregnancy Depression, and Risk of Ectopic Pregnancy. Can J Psychiatry 2020; 65:845-853
|
|
Wemakor, 2015
|
Wemakor Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol 2015; 30:1187-98
|
|
Wen, 2006
|
Wen Selective serotonin reuptake inhibitors and adverse pregnancy outcomes. Am. J. Obstet. Gynecol. 2006; 194:961-6
|
|
Wichman, 2009
|
Wichman Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy. Mayo Clin. Proc. 2009; 84:23-7
|
|
Wilson, 2011
|
Wilson Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors. Am J Perinatol 2011; 28:19-24
|
|
Wisner (Controls unexposed, disease free), 2009
|
Wisner Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166:557-66 Wisner Does fetal exposure to SSRIs or maternal depression impact infant growth? Am J Psychiatry 2013; 170:485-93
|
|
Wisner (Controls unexposed, sick), 2009
|
Wisner Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes. Am J Psychiatry 2009; 166:557-66 Wisner Does fetal exposure to SSRIs or maternal depression impact infant growth? Am J Psychiatry 2013; 170:485-93
|
|
Wu, 2019
|
Wu Association between First Trimester Antidepressant Use and Risk of Spontaneous Abortion. Pharmacotherapy 2019; 39:889-898
|
|
Yang, 2021
|
Yang Prenatal antidepressant use and the implication of hypertensive disorders during pregnancy. Am J Obstet Gynecol 2021; 225:672.e1-672.e11
|
|
Yang (Controls unexposed, disease free), 2017
|
Yang A Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates. J Clin Psychiatry 2017;78:605-611
|
|
Yang (Controls unexposed, sick), 2017
|
Yang A Neonatal Discontinuation Syndrome in Serotonergic Antidepressant-Exposed Neonates. J Clin Psychiatry 2017;78:605-611
|
|
Yaris, 2005
|
Yaris Psychotropic drugs in pregnancy: a case-control study. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005; 29:333-8
|
|
Yazdy, 2014
|
Yazdy Use of selective serotonin-reuptake inhibitors during pregnancy and the risk of clubfoot. Epidemiology 2014; 25:859-65
|
|
Yeh, 2021
|
Yeh Bipolar women's antepartum psychotropic exposure and offspring risk of attention-deficit/hyperactivity disorder and autism spectrum disorder. J Affect Disord 2021; 295:1407-1414
|
|
Zakiyah, 2018
|
Zakiyah Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study. BMC Pregnancy Childbirth 2018; 18:187
|
|
Zeskind, 2004
|
Zeskind Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 2004; 113:368-75
|
